Provectus Pharmaceuticals, Inc. , a development-stage oncology and dermatology biopharmaceutical company, announced details of a poster presentation on the induction of a systemic immune response with intralesional PV-10 by researchers from the Moffitt Cancer Center at the American Association for Cancer Research Annual Meeting in Washington, DC.
http://www.freshnews.com/news/783676/pv-10-data-presented-moffitt-cancer-center-researchers-examines-induction-systemic-immu
http://www.freshnews.com/news/783676/pv-10-data-presented-moffitt-cancer-center-researchers-examines-induction-systemic-immu
No comments:
Post a Comment